Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes.

Long, S Alice; Thorpe, Jerill; DeBerg, Hannah A; Gersuk, Vivian; Eddy, James; Harris, Kristina M; Ehlers, Mario; Herold, Kevan C; Nepom, Gerald T; Linsley, Peter S

Long, S Alice; Thorpe, Jerill; DeBerg, Hannah A; Gersuk, Vivian; Eddy, James; Harris, Kristina M; Ehlers, Mario; Herold, Kevan C; Nepom, Gerald T; Linsley, Peter S.

Afiliação

Long SA; Translational Research Program, Benaroya Research Institute, Seattle, WA.
Thorpe J; Translational Research Program, Benaroya Research Institute, Seattle, WA.
DeBerg HA; Systems Immunology, Benaroya Research Institute, Seattle, WA.
Gersuk V; Systems Immunology, Benaroya Research Institute, Seattle, WA.
Eddy J; Systems Immunology, Benaroya Research Institute, Seattle, WA.
Harris KM; Immune Tolerance Network, Bethesda, MD.
Ehlers M; Immune Tolerance Network, San Francisco, CA.
Herold KC; Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT.
Nepom GT; Immune Tolerance Network, Bethesda, MD.
Linsley PS; Systems Immunology, Benaroya Research Institute, Seattle, WA.

Sci Immunol ; 1(5)2016 Nov.

Article em En | MEDLINE | ID: mdl-28664195

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Sci Immunol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google